カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のがん早期発見市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Cancer Early Detection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17271）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17271
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のがん早期発見市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

がん早期発見市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のがん早期発見の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

がん早期発見市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・大腸がん、肝臓がん、肺がん、その他

用途別セグメントは次のように区分されます。
・病院、医療センター、その他

世界のがん早期発見市場の主要な市場プレーヤーは以下のとおりです。
・Exact Sciences、Grail、Genetron Health、New Horizon Health、Burning Rock、Berry Oncology、Shanghai Kunyuan Biotechnology、Oncognostic、Epigenomics、Abbott、Qiagen、iStat Biomedical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、がん早期発見製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要ながん早期発見メーカーの企業概要、2019年～2022年までのがん早期発見の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要ながん早期発見メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別がん早期発見の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのがん早期発見の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのがん早期発見市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびがん早期発見の産業チェーンを掲載しています。
・第13、14、15章では、がん早期発見の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- がん早期発見の概要
- 種類別分析（2017年vs2021年vs2028年）：大腸がん、肝臓がん、肺がん、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、医療センター、その他
- 世界のがん早期発見市場規模・予測
- 世界のがん早期発見生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Exact Sciences、Grail、Genetron Health、New Horizon Health、Burning Rock、Berry Oncology、Shanghai Kunyuan Biotechnology、Oncognostic、Epigenomics、Abbott、Qiagen、iStat Biomedical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：大腸がん、肝臓がん、肺がん、その他
・用途別分析2017年-2028年：病院、医療センター、その他
・がん早期発見の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・がん早期発見のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・がん早期発見のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・がん早期発見の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・がん早期発見の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Cancer Early Detection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Early Detection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Cancer Early Detection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Colorectal Cancer segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cancer Early Detection include Exact Sciences, Grail, Genetron Health, New Horizon Health, and Burning Rock, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Early Detection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Market segment by Application can be divided into
Hospital
Medical Center
Other
The key market players for global Cancer Early Detection market are listed below:
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Early Detection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Early Detection, with price, sales, revenue and global market share of Cancer Early Detection from 2019 to 2022.
Chapter 3, the Cancer Early Detection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Early Detection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Early Detection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Early Detection.
Chapter 13, 14, and 15, to describe Cancer Early Detection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Cancer Early Detection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Early Detection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Early Detection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Global Cancer Early Detection Market Size & Forecast
1.4.1 Global Cancer Early Detection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cancer Early Detection Sales in Volume (2017-2028)
1.4.3 Global Cancer Early Detection Price (2017-2028)
1.5 Global Cancer Early Detection Production Capacity Analysis
1.5.1 Global Cancer Early Detection Total Production Capacity (2017-2028)
1.5.2 Global Cancer Early Detection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Early Detection Market Drivers
1.6.2 Cancer Early Detection Market Restraints
1.6.3 Cancer Early Detection Trends Analysis
2 Manufacturers Profiles
2.1 Exact Sciences
2.1.1 Exact Sciences Details
2.1.2 Exact Sciences Major Business
2.1.3 Exact Sciences Cancer Early Detection Product and Services
2.1.4 Exact Sciences Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grail
2.2.1 Grail Details
2.2.2 Grail Major Business
2.2.3 Grail Cancer Early Detection Product and Services
2.2.4 Grail Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genetron Health
2.3.1 Genetron Health Details
2.3.2 Genetron Health Major Business
2.3.3 Genetron Health Cancer Early Detection Product and Services
2.3.4 Genetron Health Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 New Horizon Health
2.4.1 New Horizon Health Details
2.4.2 New Horizon Health Major Business
2.4.3 New Horizon Health Cancer Early Detection Product and Services
2.4.4 New Horizon Health Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Burning Rock
2.5.1 Burning Rock Details
2.5.2 Burning Rock Major Business
2.5.3 Burning Rock Cancer Early Detection Product and Services
2.5.4 Burning Rock Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Berry Oncology
2.6.1 Berry Oncology Details
2.6.2 Berry Oncology Major Business
2.6.3 Berry Oncology Cancer Early Detection Product and Services
2.6.4 Berry Oncology Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shanghai Kunyuan Biotechnology
2.7.1 Shanghai Kunyuan Biotechnology Details
2.7.2 Shanghai Kunyuan Biotechnology Major Business
2.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection Product and Services
2.7.4 Shanghai Kunyuan Biotechnology Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Oncognostic
2.8.1 Oncognostic Details
2.8.2 Oncognostic Major Business
2.8.3 Oncognostic Cancer Early Detection Product and Services
2.8.4 Oncognostic Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Epigenomics
2.9.1 Epigenomics Details
2.9.2 Epigenomics Major Business
2.9.3 Epigenomics Cancer Early Detection Product and Services
2.9.4 Epigenomics Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business
2.10.3 Abbott Cancer Early Detection Product and Services
2.10.4 Abbott Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Qiagen
2.11.1 Qiagen Details
2.11.2 Qiagen Major Business
2.11.3 Qiagen Cancer Early Detection Product and Services
2.11.4 Qiagen Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 iStat Biomedical
2.12.1 iStat Biomedical Details
2.12.2 iStat Biomedical Major Business
2.12.3 iStat Biomedical Cancer Early Detection Product and Services
2.12.4 iStat Biomedical Cancer Early Detection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cancer Early Detection Breakdown Data by Manufacturer
3.1 Global Cancer Early Detection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cancer Early Detection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cancer Early Detection
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Early Detection Manufacturer Market Share in 2021
3.4.2 Top 6 Cancer Early Detection Manufacturer Market Share in 2021
3.5 Global Cancer Early Detection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cancer Early Detection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cancer Early Detection Market Size by Region
4.1.1 Global Cancer Early Detection Sales in Volume by Region (2017-2028)
4.1.2 Global Cancer Early Detection Revenue by Region (2017-2028)
4.2 North America Cancer Early Detection Revenue (2017-2028)
4.3 Europe Cancer Early Detection Revenue (2017-2028)
4.4 Asia-Pacific Cancer Early Detection Revenue (2017-2028)
4.5 South America Cancer Early Detection Revenue (2017-2028)
4.6 Middle East and Africa Cancer Early Detection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cancer Early Detection Sales in Volume by Type (2017-2028)
5.2 Global Cancer Early Detection Revenue by Type (2017-2028)
5.3 Global Cancer Early Detection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cancer Early Detection Sales in Volume by Application (2017-2028)
6.2 Global Cancer Early Detection Revenue by Application (2017-2028)
6.3 Global Cancer Early Detection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cancer Early Detection Sales by Type (2017-2028)
7.2 North America Cancer Early Detection Sales by Application (2017-2028)
7.3 North America Cancer Early Detection Market Size by Country
7.3.1 North America Cancer Early Detection Sales in Volume by Country (2017-2028)
7.3.2 North America Cancer Early Detection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cancer Early Detection Sales by Type (2017-2028)
8.2 Europe Cancer Early Detection Sales by Application (2017-2028)
8.3 Europe Cancer Early Detection Market Size by Country
8.3.1 Europe Cancer Early Detection Sales in Volume by Country (2017-2028)
8.3.2 Europe Cancer Early Detection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cancer Early Detection Sales by Type (2017-2028)
9.2 Asia-Pacific Cancer Early Detection Sales by Application (2017-2028)
9.3 Asia-Pacific Cancer Early Detection Market Size by Region
9.3.1 Asia-Pacific Cancer Early Detection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cancer Early Detection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cancer Early Detection Sales by Type (2017-2028)
10.2 South America Cancer Early Detection Sales by Application (2017-2028)
10.3 South America Cancer Early Detection Market Size by Country
10.3.1 South America Cancer Early Detection Sales in Volume by Country (2017-2028)
10.3.2 South America Cancer Early Detection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cancer Early Detection Sales by Type (2017-2028)
11.2 Middle East & Africa Cancer Early Detection Sales by Application (2017-2028)
11.3 Middle East & Africa Cancer Early Detection Market Size by Country
11.3.1 Middle East & Africa Cancer Early Detection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cancer Early Detection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cancer Early Detection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cancer Early Detection
12.3 Cancer Early Detection Production Process
12.4 Cancer Early Detection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cancer Early Detection Typical Distributors
13.3 Cancer Early Detection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Cancer Early Detection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Cancer Early Detection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 4. Exact Sciences Major Business
Table 5. Exact Sciences Cancer Early Detection Product and Services
Table 6. Exact Sciences Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Grail Basic Information, Manufacturing Base and Competitors
Table 8. Grail Major Business
Table 9. Grail Cancer Early Detection Product and Services
Table 10. Grail Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Genetron Health Basic Information, Manufacturing Base and Competitors
Table 12. Genetron Health Major Business
Table 13. Genetron Health Cancer Early Detection Product and Services
Table 14. Genetron Health Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. New Horizon Health Basic Information, Manufacturing Base and Competitors
Table 16. New Horizon Health Major Business
Table 17. New Horizon Health Cancer Early Detection Product and Services
Table 18. New Horizon Health Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Burning Rock Basic Information, Manufacturing Base and Competitors
Table 20. Burning Rock Major Business
Table 21. Burning Rock Cancer Early Detection Product and Services
Table 22. Burning Rock Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Berry Oncology Basic Information, Manufacturing Base and Competitors
Table 24. Berry Oncology Major Business
Table 25. Berry Oncology Cancer Early Detection Product and Services
Table 26. Berry Oncology Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shanghai Kunyuan Biotechnology Basic Information, Manufacturing Base and Competitors
Table 28. Shanghai Kunyuan Biotechnology Major Business
Table 29. Shanghai Kunyuan Biotechnology Cancer Early Detection Product and Services
Table 30. Shanghai Kunyuan Biotechnology Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Oncognostic Basic Information, Manufacturing Base and Competitors
Table 32. Oncognostic Major Business
Table 33. Oncognostic Cancer Early Detection Product and Services
Table 34. Oncognostic Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Epigenomics Basic Information, Manufacturing Base and Competitors
Table 36. Epigenomics Major Business
Table 37. Epigenomics Cancer Early Detection Product and Services
Table 38. Epigenomics Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Abbott Basic Information, Manufacturing Base and Competitors
Table 40. Abbott Major Business
Table 41. Abbott Cancer Early Detection Product and Services
Table 42. Abbott Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Qiagen Basic Information, Manufacturing Base and Competitors
Table 44. Qiagen Major Business
Table 45. Qiagen Cancer Early Detection Product and Services
Table 46. Qiagen Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. iStat Biomedical Basic Information, Manufacturing Base and Competitors
Table 48. iStat Biomedical Major Business
Table 49. iStat Biomedical Cancer Early Detection Product and Services
Table 50. iStat Biomedical Cancer Early Detection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Cancer Early Detection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Cancer Early Detection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Cancer Early Detection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Cancer Early Detection Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Cancer Early Detection Production Site of Key Manufacturer
Table 56. Cancer Early Detection New Entrant and Capacity Expansion Plans
Table 57. Cancer Early Detection Mergers & Acquisitions in the Past Five Years
Table 58. Global Cancer Early Detection Sales by Region (2017-2022) & (K Units)
Table 59. Global Cancer Early Detection Sales by Region (2023-2028) & (K Units)
Table 60. Global Cancer Early Detection Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Cancer Early Detection Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Cancer Early Detection Sales by Type (2017-2022) & (K Units)
Table 63. Global Cancer Early Detection Sales by Type (2023-2028) & (K Units)
Table 64. Global Cancer Early Detection Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Cancer Early Detection Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Cancer Early Detection Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Cancer Early Detection Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Cancer Early Detection Sales by Application (2017-2022) & (K Units)
Table 69. Global Cancer Early Detection Sales by Application (2023-2028) & (K Units)
Table 70. Global Cancer Early Detection Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Cancer Early Detection Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Cancer Early Detection Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Cancer Early Detection Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Cancer Early Detection Sales by Country (2017-2022) & (K Units)
Table 75. North America Cancer Early Detection Sales by Country (2023-2028) & (K Units)
Table 76. North America Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Cancer Early Detection Sales by Type (2017-2022) & (K Units)
Table 79. North America Cancer Early Detection Sales by Type (2023-2028) & (K Units)
Table 80. North America Cancer Early Detection Sales by Application (2017-2022) & (K Units)
Table 81. North America Cancer Early Detection Sales by Application (2023-2028) & (K Units)
Table 82. Europe Cancer Early Detection Sales by Country (2017-2022) & (K Units)
Table 83. Europe Cancer Early Detection Sales by Country (2023-2028) & (K Units)
Table 84. Europe Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Cancer Early Detection Sales by Type (2017-2022) & (K Units)
Table 87. Europe Cancer Early Detection Sales by Type (2023-2028) & (K Units)
Table 88. Europe Cancer Early Detection Sales by Application (2017-2022) & (K Units)
Table 89. Europe Cancer Early Detection Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Cancer Early Detection Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Cancer Early Detection Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Cancer Early Detection Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Cancer Early Detection Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Cancer Early Detection Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Cancer Early Detection Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Cancer Early Detection Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Cancer Early Detection Sales by Application (2023-2028) & (K Units)
Table 98. South America Cancer Early Detection Sales by Country (2017-2022) & (K Units)
Table 99. South America Cancer Early Detection Sales by Country (2023-2028) & (K Units)
Table 100. South America Cancer Early Detection Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Cancer Early Detection Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Cancer Early Detection Sales by Type (2017-2022) & (K Units)
Table 103. South America Cancer Early Detection Sales by Type (2023-2028) & (K Units)
Table 104. South America Cancer Early Detection Sales by Application (2017-2022) & (K Units)
Table 105. South America Cancer Early Detection Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Cancer Early Detection Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Cancer Early Detection Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Cancer Early Detection Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Cancer Early Detection Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Cancer Early Detection Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Cancer Early Detection Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Cancer Early Detection Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Cancer Early Detection Sales by Application (2023-2028) & (K Units)
Table 114. Cancer Early Detection Raw Material
Table 115. Key Manufacturers of Cancer Early Detection Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Cancer Early Detection Typical Distributors
Table 119. Cancer Early Detection Typical Customers
List of Figures
Figure 1. Cancer Early Detection Picture
Figure 2. Global Cancer Early Detection Revenue Market Share by Type in 2021
Figure 3. Colorectal Cancer
Figure 4. Liver Cancer
Figure 5. Lung Cancer
Figure 6. Other
Figure 7. Global Cancer Early Detection Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Medical Center
Figure 10. Other
Figure 11. Global Cancer Early Detection Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Cancer Early Detection Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Cancer Early Detection Sales (2017-2028) & (K Units)
Figure 14. Global Cancer Early Detection Price (2017-2028) & (US$/Unit)
Figure 15. Global Cancer Early Detection Production Capacity (2017-2028) & (K Units)
Figure 16. Global Cancer Early Detection Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Cancer Early Detection Market Drivers
Figure 18. Cancer Early Detection Market Restraints
Figure 19. Cancer Early Detection Market Trends
Figure 20. Global Cancer Early Detection Sales Market Share by Manufacturer in 2021
Figure 21. Global Cancer Early Detection Revenue Market Share by Manufacturer in 2021
Figure 22. Cancer Early Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Cancer Early Detection Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Cancer Early Detection Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Cancer Early Detection Sales Market Share by Region (2017-2028)
Figure 26. Global Cancer Early Detection Revenue Market Share by Region (2017-2028)
Figure 27. North America Cancer Early Detection Revenue (2017-2028) & (USD Million)
Figure 28. Europe Cancer Early Detection Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Cancer Early Detection Revenue (2017-2028) & (USD Million)
Figure 30. South America Cancer Early Detection Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Cancer Early Detection Revenue (2017-2028) & (USD Million)
Figure 32. Global Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 33. Global Cancer Early Detection Revenue Market Share by Type (2017-2028)
Figure 34. Global Cancer Early Detection Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 36. Global Cancer Early Detection Revenue Market Share by Application (2017-2028)
Figure 37. Global Cancer Early Detection Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 39. North America Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 40. North America Cancer Early Detection Sales Market Share by Country (2017-2028)
Figure 41. North America Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 42. United States Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 46. Europe Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 47. Europe Cancer Early Detection Sales Market Share by Country (2017-2028)
Figure 48. Europe Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 49. Germany Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Cancer Early Detection Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Cancer Early Detection Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Cancer Early Detection Revenue Market Share by Region (2017-2028)
Figure 58. China Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 65. South America Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 66. South America Cancer Early Detection Sales Market Share by Country (2017-2028)
Figure 67. South America Cancer Early Detection Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Cancer Early Detection Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Cancer Early Detection Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Cancer Early Detection Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Cancer Early Detection Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Cancer Early Detection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Cancer Early Detection in 2021
Figure 79. Manufacturing Process Analysis of Cancer Early Detection
Figure 80. Cancer Early Detection Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の膀胱がん検出キット市場2022年：市場規模予測（～2028年）
  • 世界の迅速ながん検査キット市場2022年：市場規模予測（～2028年）
  • 世界のがん用PARP阻害剤市場2022年：市場規模予測（～2028年）
  • 腫瘍NGS検出のグローバル市場展望 2023年-2029年：医療機器、消耗品
  • 世界の新興がんワクチン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17271 )"世界のがん早期発見市場2022年：市場規模予測（～2028年）" (英文：Global Cancer Early Detection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。